Minerva Neurosciences, Inc. Repayments of Senior Debt
Minerva Neurosciences, Inc. (NERV) reported Repayments of Senior Debt of $4.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSeniorDebt · last filed 2020-03-09
- Minerva Neurosciences, Inc. repayments of senior debt for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- Minerva Neurosciences, Inc. repayments of senior debt for the quarter ending 2018-09-30 was $1.40M, a 12.26% increase year-over-year.
- Minerva Neurosciences, Inc. repayments of senior debt for the quarter ending 2018-06-30 was $1.31M, a 7.28% increase year-over-year.
- Minerva Neurosciences, Inc. repayments of senior debt for the quarter ending 2018-03-31 was $1.29M, a 7.28% increase year-over-year.
- Minerva Neurosciences, Inc. repayments of senior debt for fiscal 2018 was $4.00M, a 18.99% decline from fiscal 2017.
- Minerva Neurosciences, Inc. repayments of senior debt for fiscal 2017 was $4.94M, a 214.45% increase from fiscal 2016.
- Minerva Neurosciences, Inc. repayments of senior debt for fiscal 2016 was $1.57M.
- Minerva Neurosciences, Inc. repayments of senior debt for fiscal 2014 was $1.88M.
| Period end | Repayments of Senior Debt 3 month | Repayments of Senior Debt 6 month | Repayments of Senior Debt 9 month | Repayments of Senior Debt 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $1.40M derived: sum of 2 quarters · filed 2020-03-09 | $2.71M derived: sum of 3 quarters · filed 2020-03-09 | $4.00M 10-K · filed 2020-03-09 |
| 2018-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $2.71M derived: sum of 2 quarters · filed 2019-11-04 | $4.00M 10-Q · filed 2019-11-04 | $5.27M derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $2.60M 10-Q · filed 2019-08-05 | $3.87M derived: sum of 3 quarters · filed 2019-08-05 | $5.12M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | $1.29M 10-Q · filed 2019-05-06 | $2.56M derived: sum of 2 quarters · filed 2019-05-06 | $3.80M derived: sum of 3 quarters · filed 2019-05-06 | $5.03M derived: sum of 4 quarters · filed 2019-05-06 |
| 2017-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $2.51M derived: sum of 2 quarters · filed 2019-03-12 | $3.74M derived: sum of 3 quarters · filed 2019-03-12 | $4.94M 10-K · filed 2019-03-12 |
| 2017-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $2.47M derived: sum of 2 quarters · filed 2018-11-05 | $3.67M 10-Q · filed 2018-11-05 | $4.85M derived: sum of 4 quarters · filed 2018-11-05 |
| 2017-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $2.43M 10-Q · filed 2018-08-02 | $3.61M derived: sum of 3 quarters · filed 2018-08-02 | |
| 2017-03-31 | $1.20M 10-Q · filed 2018-05-03 | $2.38M derived: sum of 2 quarters · filed 2018-05-03 | ||
| 2016-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $1.57M 10-K · filed 2018-03-12 | ||
| 2016-09-30 | $389.20K 10-Q · filed 2017-11-06 | |||
| 2014-12-31 | $1.88M 10-K · filed 2017-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |